PHOENIX — The Mayo Clinic Board of Trustees welcomed Michael Dougherty, founder and chairman of Dougherty Financial Group LLC, as a new member during a meeting today. The trustees also recognized two recipients of Mayo Clinic named professorships and two retiring members, elected three new and re-elected two internal trustees and named officers for 2013.
Dougherty will serve a four-year term as an external trustee. Dougherty Financial Group is the parent company to Dougherty & Company LLC, a full-service investment-banking firm with three affiliated companies. Dougherty received his Bachelor of Arts degree from the University of St. Thomas, St. Paul, Minn. and also serves on the university's board of trustees and is chair of the executive committee. He currently serves on the board of directors for Forestar Group Inc., Austin, Texas.
Veronique Roger, M.D., a cardiologist in the Division of Cardiovascular Diseases with an appointment also in the Department of Health Sciences Research at Mayo Clinic, is recognized as the Elizabeth C. Lane, Ph.D., and M. Nadine Zimmerman, Ph.D., Professor in Internal Medicine. Dr. Lane, who died in 2011, was a professor of physical education at Northern Illinois University from 1954–1982. She was a fellow of the American College of Sports Medicine. Dr. Zimmerman taught at the university for 34 years and served in administrative leadership roles.
Dr. Roger is director of Mayo Clinic's Center for the Science of Health Care Delivery and a professor of medicine and epidemiology at the Mayo Clinic College of Medicine. Using population science methods, Dr. Roger works to understand factors behind diseases and their outcomes in large-scale population studies, focusing on heart failure and coronary artery disease. Her research is funded by the National Heart, Lung, and Blood Institute and the American Heart Association. Dr. Roger works with the Center for the Science of Health Care Delivery to test and put into place health care delivery models that improve patient outcomes.
Evanthia Galanis, M.D., an oncologist in the Department of Oncology and Department of Molecular Medicine, is recognized as The Sandra J. Schulze Professor. The Richard M. Schulze Family Foundation funded the professorship and established a center dedicated to the discovery, development and use of cancer therapies. The center focuses on treatments that save lives and enhance patients' quality of life. The Mayo Clinic Schulze Center for Novel Therapeutics is recognized on the 19th floor of the Gonda Building.
Dr. Galanis is an oncology professor and chair of the Department of Molecular Medicine, which is involved in gene therapy and using viruses to treat cancer. Dr. Galanis's work focuses on targeted treatments based on the molecular characteristics of a patient's tumor. Her laboratory is developing virotherapy and gene transfer strategies for the treatment of solid tumors, especially in brain, breast and prostate cancer. She is also researching the combination of viral therapeutics with other treatments such as radiation therapy and small molecule cell cycle inhibitors. She is the lead researcher in multiple Mayo-based and national clinical trials.
The Board of Trustees named Mayo Clinic's officers for 2013. They are Marilyn Carlson Nelson, chair; John Noseworthy, M.D., president and CEO; vice presidents: Shirley Weis, chief administrative officer, William Rupp, M.D., and Wyatt Decker, M.D.; Jeffrey Bolton, chief financial officer; Jonathan Oviatt, secretary; and Harry Hoffman, treasurer.
Daniel Berry, M.D., chair of Orthopedic Surgery at Mayo Clinic in Rochester and Lois Krahn, M.D., Psychiatry and Psychology and the Sleep Disorders Center at Mayo Clinic in Arizona, were named internal trustees and will serve four-year terms. Mary Jo Williamson, the chief administrator for the Mayo Clinic Care Network, was elected to a one-year term.
Dawn Milliner, M.D., a nephrologist in Nephrology and Hypertension and Pediatric and Adolescent Medicine, was re-elected as an internal trustee and will serve a four-year term. Robert Nesse, M.D., CEO, Mayo Clinic Health System, was re-elected as an internal trustee and will serve one year.
The Board of Trustees recognized four retiring members:
The Mayo Clinic Board of Trustees, a 31-member group of public representatives and Mayo Clinic physicians and administrators, is responsible for patient care, medical education and research at Mayo Clinic's sites in Jacksonville, Fla.; Rochester, Minn.; and Phoenix and Scottsdale, Ariz.Posted by mayonewsreleases